Industry Needs Solid Regulations Now To Counterbalance Europe’s Tough Challenges
Executive Summary
Rising energy costs, challenges in accessing supplies and rapidly changing technology are all factors that mean industry needs a certain and established regulatory structure to help it cope.
You may also be interested in...
EU Drug Supply In Jeopardy Without Energy Support, Warns Industry Group
Industry body Medicines for Europe is calling for pharmaceutical manufacturers to be excluded from energy restriction policies for winter 2022 in an open letter to EU governance bodies. It warns that inflation and energy costs threaten European drug makers with closures and rationing.
EU Drug Supply In Jeopardy Without Energy Support, Warns Medicines For Europe
Medicines for Europe calls for the pharmaceutical industry to be excluded from energy restriction policies for winter 2022 in an open letter to EU governance bodies. Inflation and energy costs threaten European drug makers with closures and rationing, says the industry body.
European Commission Launches Data Collection Initiative To Avoid Medtech Product Shortfalls
There is a much-acknowledged urgency to ensure medtech products are certified as fast as possible, with fears persisting that delays will result in notified body bottlenecks and product shortages.